Bayer Roundup Settlement Proposed Amid Appeal

Bayer Roundup settlement proposal shifts legal risk as the U.S. Supreme Court readies an appeal; investors eye liability and strategy.

February 18, 2026·2 min read
View all news articles
Flat vector of an agrochemical canister with a gavel shadow symbolizing Bayer Roundup settlement and legal risk.

KEY TAKEAWAYS

  • Bayer proposed a $10.5B settlement combining a $7.5B class fund and $3B for existing U.S. cases.
  • The framework covers roughly 67,000 outstanding claims and includes no admission of wrongdoing or liability.
  • It was framed alongside a pending Supreme Court appeal of a $1.25M 2023 verdict, complicating Bayer's legal exposure.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Bayer AG proposed a $10.5 billion settlement on February 17, 2026, as the U.S. Supreme Court prepares to hear the company’s appeal of a 2023 verdict. The move reshapes the legal stakes in the long-running glyphosate litigation tied to its Roundup herbicide.

Settlement Terms and Legal Strategy

The proposed settlement includes a $7.5 billion Missouri state-court class fund covering claims over 20 years and $3 billion to resolve existing individual U.S. cases. Bayer has not admitted wrongdoing or liability in connection with the settlement.

The company faces roughly 67,000 outstanding claims alleging that long-term glyphosate exposure caused non-Hodgkin lymphoma. Bayer has already paid more than $10 billion in verdicts and settlements since acquiring Monsanto for $66 billion, inheriting the litigation.

In January 2026, the U.S. Supreme Court agreed to hear Bayer’s appeal of a 2023 Missouri jury verdict of $1.25 million. The appeal raises federal-preemption questions central to Bayer’s defense, which cites the U.S. Food and Drug Administration’s finding that glyphosate is not a carcinogen.

CEO Bill Anderson described the class settlement as an important addition to Bayer’s Supreme Court case and said he is considering whether to stop producing glyphosate because of the litigation burden. The settlement’s structure reflects a dual legal strategy: it aims to manage future claims through a long-term mechanism while the Supreme Court determines whether federal law limits some state-law claims. This decision could significantly affect the geographic and legal scope of Bayer’s liability in Roundup litigation.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Meta EU DSA Charges Over Underage Access

Meta EU DSA Charges Over Underage Access

Meta EU DSA charges raise compliance and penalty risk after EU preliminary findings on underage access and prompt investor scrutiny and positioning shifts.

Fed Likely To Hold Rates as Powell's Final Meeting Nears

Fed Likely To Hold Rates as Powell's Final Meeting Nears

Fed Likely To Hold Rates as traders price a hold at the April 29 FOMC and futures push the first expected cut to late 2027, limiting 2026-cut bets.

SoFi Earnings: Shares Tumble After Q1 Report

SoFi Earnings: Shares Tumble After Q1 Report

SoFi earnings showed $1.1B Q1 revenue and member growth but unchanged FY guidance and softer Q2 revenue guide sent shares down about 9.0% premarket.

Alphabet Q1 2026 Earnings Preview

Alphabet Q1 2026 Earnings Preview

Alphabet Q1 2026 earnings are due April 29; investors will watch Google Cloud growth and $175-$185 billion capex guidance for margin progress.

Bloom Energy Earnings Rise on AI Data-Center Demand

Bloom Energy Earnings Rise on AI Data-Center Demand

Bloom Energy earnings showed record Q1 results and raised 2026 guide on AI data-center demand and Oracle Project Jupiter, supporting a share re-rating.

Pernod Ricard Brown-Forman Merger Ends

Pernod Ricard Brown-Forman Merger Ends

Pernod Ricard Brown-Forman merger talks ended April 28; Brown-Forman shares fell about 5.9% as investors weighed demand and a $15 billion Sazerac bid.